Concurrent 6B: Abstract Session - Integrated Care: From the Hospital to the Community
Tracks
Track 2
Friday, October 17, 2025 |
11:45 AM - 1:15 PM |
Speaker
Professor Peter Vickerman
Professor Of Infectious Disease Modelling
University Of Bristol
ESTIMATING THE POTENTIAL IMPACT OF INTEGRATING THE PROVISION OF HIV PRE-EXPOSURE PROPHYLAXIS THROUGH HARM REDUCTION INTERVENTIONS FOR PEOPLE WHO INJECT DRUGS
11:45 AM - 12:00 PMBiography
Professor Peter Vickerman has 30 years’ experience of infectious disease modelling. His research focuses on using modelling to help understand the transmission of infectious diseases and impact/cost-effectiveness of prevention measures amongst key populations in different global settings, especially HIV and HCV among people who use drugs.
Mrs Yevheniia Zakrevska
Senior Program Manager
Icf "Alliance For Public Health"
Ms Mariam El Sheikh
Phd Student
Mcgill University
THE IMPACT OF ENGAGEMENT IN HEPATITIS C (HCV) CARE ON THE SKIN AND SOFT TISSUE INFECTIONS HEALTHCARE BURDEN AMONG PEOPLE WHO INJECT DRUGS IN QUEBEC, CANADA
12:15 PM - 12:30 PMBiography
Mariam is a PhD candidate in Epidemiology at McGill University, where she also completed her Master of Science in Public Health. She is interested in identifying gaps in care people who inject drugs and are living with HCV face to inform holistic elimination strategies that improve overall health outcomes.
Dr Cathy Long
Research Consultant
Unity Health Toronto
STAFF AND CLINICIAN PERSPECTIVES ON RISKS ENCOUNTERED BY PEOPLE WHO USE DRUGS IN AN ACUTE CARE HOSPITAL SETTING
12:30 PM - 12:45 PMBiography
Cathy Long is a community-based researcher whose work seeks to understand and respond to gaps in social and health services, with an emphasis on equity for people who use substances and people experiencing homelessness. Long has a PhD in social and behavioural health sciences from the University of Toronto.
Dr Brendan Jacka
Senior Research Associate
The Kirby Institute, UNSW Sydney
INCIDENCE, PATIENT-DIRECTED DISCHARGE, READMISSION, AND MORTALITY AMONG PEOPLE HOSPITALIZED WITH INJECTING-RELATED INFECTION: A POPULATION-BASED LINKAGE STUDY
12:45 PM - 12:50 PMBiography
Dr. Jacka is a Senior Research Associate in the Therapeutics and Vaccines Research Program (TVRP) of the Kirby Institute. His research focus on understanding health outcomes and developing better models of care for prevention and treatment of infectious diseases in marginalised communities.
Mr. Mohammad Shoriful Alam
Technical Specialist-CSS (PWID)
Save The Children in Bangladesh
PILOTING THE MANAGEMENT OF HEPATITIS C VIRUS (HCV) INFECTION AMONG HIV POSITIVE PEOPLE WHO INJECT DRUGS (PWID) IN BANGLADESH
12:50 PM - 12:55 PMBiography
Mohammad Shoriful Alam (MPH), native of Bangladesh working around twenty years as an activist in the area of HIV Intervention program among PWID and PLHIV.
Mr Steven Batur
M & E Advisor
Kncv Tuberculosis Nigeria
LEVERAGING DATA ANALYTICS FOR OPTIMIZING TB AND HIV CASE DETECTIONAMONG KEY POPULATION IN NIGERIA:INSIGHTS FROM THE KNCV GF CPPM GRANT
12:55 PM - 1:00 PMBiography
Steven Liamngee Batur is an M&E Specialist with expertise in data management, project evaluation, and strategic information. He holds an MSc in Information Technology a. With over a decade of experience, he has led data-driven initiatives for Global Fund, USAID, and CDC-supported public health programs in Nigeria
Mr Edward Mbizo Sibanda
Key Populations Programme Manager
Beyond Zero
Ms Michelle Pittman
Nurse Practitioner
RECAP Health Services & Horizon Health
THE POWER OF NURSING: DRIVING HEPATITIS C MICRO-ELIMINATION WITHIN NEW BRUNSWICK’S INJECTABLE OPIOID AGONIST THERAPY PROGRAM
1:05 PM - 1:10 PMBiography
Michelle, became a Nurse Practitioner in 2023, through Athabasca University, and was clinic manager at River Stone Recovery Centre (2020-2024). She specializes in addiction medicine, mental health, and Hepatitis C care. She started a nurse-led HCV program and advocates for policy change through Action Hepatitis Canada while balancing family life.
Dr Jacqui Richmond
Workforce Development And Health Service Delivery Lead, Elimination Hepatitis C Australia
Burnet Institute
CONTINUING THE DISCUSSION ABOUT PEER-NURSE PARTNERSHIPS IN HEPATITIS C ELIMINATION EFFORTS
1:10 PM - 1:15 PMBiography
Jacqui is a nurse working at the Burnet Institute in the Eliminate hepatitis C Australia partnership.
Jane works at Harm Reduction Victoria and is an advocate of peer work and lived experience and is passionate about the health and human rights of people who use drugs.
Ms Jane Dicka
Health Promotion Coordinator
Harm Reduction Victoria
CONTINUING THE DISCUSSION ABOUT PEER-NURSE PARTNERSHIPS IN HEPATITIS C ELIMINATION EFFORTS
1:10 PM - 1:15 PMBiography
Jane has been working with people who use drugs in various front line roles for more than twenty years. She currently coordinates the health promotion team and the DOPE project at Harm Reduction Victoria. She has a seat on the board of AIVL, the peak body for drug user organisations in Australia and INPUD, the International Network of People Who Use Drugs.
She is passionate about the health and human rights of people who use drugs and is a strong advocate against stigma and discrimination toward her community.
She is a huge dog lover who also happens to be dependent on cheesy reality television and heroin.
